🟢 Biovie is trading 5.62% up in pre-market after broader risk sentiment improved overnight

Biovie is trading 5.62% higher at $1.88 after broader risk sentiment improved overnight.

• U.S. futures are higher, with the Nasdaq Composite up 0.52%.
• Markets responded positively to the Bank of Japan’s expected rate hike and dovish split vote.
• No fresh company-specific catalyst was identified for September 18; the latest major company news was the September 15 Long COVID trial update. The move appears primarily global and market-driven, not tied to new Biovie fundamentals.